N-3 fatty acids for improvement of Respiratory Outcomes - The N3RO trial



Docosahexaenoic acid for the reduction of bronchopulomonary dysplasia in preterm infants born at less than 29 weeks gestational age: a randomised controlled trial
Date made available2023
PublisherSouth Australian Health and Medical Research Institute
Temporal coverage12 Jul 2012 - 22 May 2022
Date of data production2023
Geographical coverageSouth Australia Victoria Queensland Western Australia New South Wales

Cite this